SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)
[] [v360053_ex31-1.htm 2 EX-31.1] [v360053_ex31-2.htm 3 EX-31.2] [v360053_ex32-1.htm 4 EX-32.1] [v360053_ex32-2.htm 5 EX-32.2]
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS Page 3 4 2 WuXi PharmaTech (Cayman) Inc.]
WX [WuXi PharmaTech (Cayman)] 6-K: Form 6-K TABLE OF CONTENTS Page 3 4
[Form 6-K TABLE OF CONTENTS Page 3 4 2 WuXi PharmaTech (Cayman) Inc.]
WX [WuXi PharmaTech (Cayman)] 6-K: Form 6-K TABLE OF CONTENTS 3 4 2
[Form 6-K TABLE OF CONTENTS 3 4 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer]
CPHI [CHINA PHARMAS,] DEFA14A: (Original Filing)
[Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1)]
CPHI [CHINA PHARMAS,] DEFA14A: Payment of Filing Fee (Check the appropriate box):
[Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1)]
CPHI [CHINA PHARMAS,] DEF 14A: (Original Filing)
[Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]
CPHI [CHINA PHARMAS,] DEF 14A: Payment of Filing Fee (Check the appropriate box):
[Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]
CPHI [CHINA PHARMAS,] DEFA14A: (Original Filing)
[Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2)gregate number of securities to which transaction applies: (3) (4) Proposed maximumgregate value of transaction:]
CPHI [CHINA PHARMAS,] DEFA14A: Payment of Filing Fee (Check the appropriate box):
[Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2)gregate number of securities to which transaction applies: (3) (4) Proposed maximumgregate value of transaction:]
